G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Revenue

G&E Herbal Biotechnology had revenue of 32.22M TWD in the quarter ending March 31, 2026, a decrease of -59.80%. This brings the company's revenue in the last twelve months to 261.21M, down -4.59% year-over-year. In the year 2025, G&E Herbal Biotechnology had annual revenue of 309.13M with 24.13% growth.

• Revenue (ttm): 261.21M
• Revenue Growth: -4.59%
• P/S Ratio: 7.75
• Revenue / Employee: 6.07M
• Employees: 43
• Market Cap: 2.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	309.13M	60.10M	24.13%
Dec 31, 2024	249.03M	67.59M	37.25%
Dec 31, 2023	181.44M	116.84M	180.84%
Dec 31, 2022	64.61M	40.04M	162.94%
Dec 31, 2021	24.57M	-3.66M	-12.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error